We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAMR icon
3651
Lamar Advertising Co
LAMR
$15.8B
$1.77M ﹤0.01%
23,793
+4,777
+25% +$348K
ORBK
3652
DELISTED
Orbotech Ltd
ORBK
$1.76M ﹤0.01%
35,125
-12,478
-26% -$608K
TMX
3653
PUT
DELISTED
Terminix Global Holdings, Inc.
TMX
$1.76M ﹤0.01%
+51,359
New +$1.65M
KGC icon
3654
CALL
Kinross Gold
KGC
$31.9B
$1.76M ﹤0.01%
407,800
+97,800
+32% +$407K
PTLA
3655
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.76M ﹤0.01%
36,200
+3,700
+11% +$187K
GDXJ icon
3656
VanEck Junior Gold Miners ETF
GDXJ
$8.33B
$1.76M ﹤0.01%
51,608
-181,771
-78% -$5.93M
KYNB
3657
PUT
Kyntra Bio
KYNB
$28.5M
$1.76M ﹤0.01%
1,484
-168
-10% -$211K
PENN icon
3658
CALL
PENN Entertainment
PENN
$2.53B
$1.76M ﹤0.01%
56,100
+22,700
+68% +$613K
APTV icon
3659
CALL
Aptiv
APTV
$10.2B
$1.76M ﹤0.01%
20,700
-59,100
-74% -$5.63M
REN
3660
PUT
DELISTED
Resolute Energy Corporaton
REN
$1.76M ﹤0.01%
55,800
-5,100
-8% -$148K
ALGT icon
3661
PUT
Allegiant Air
ALGT
$2.36B
$1.75M ﹤0.01%
11,300
-3,900
-26% -$551K
HZN
3662
DELISTED
Horizon Global Corporation
HZN
$1.75M ﹤0.01%
124,727
+65,334
+110% +$990K
EVRI
3663
DELISTED
Everi Holdings
EVRI
$1.75M ﹤0.01%
231,383
-117,181
-34% -$945K
THR
3664
DELISTED
Thermon Group Holdings
THR
$1.74M ﹤0.01%
73,587
-58,645
-44% -$1.28M
TUP
3665
DELISTED
Tupperware Brands Corporation
TUP
$1.74M ﹤0.01%
27,750
-36,447
-57% -$2.23M
QIWI
3666
PUT
DELISTED
QIWI PLC
QIWI
$1.74M ﹤0.01%
100,400
+76,500
+320% +$1.22M
HAPN
3667
Happen Inc
HAPN
$2.27B
$1.74M ﹤0.01%
84,187
-112,145
-57% -$2.79M
UCTT
3668
PUT
Ultra Clean Holdings
UCTT
$4.21B
$1.74M ﹤0.01%
75,300
+33,000
+78% +$846K
NBL
3669
CALL
DELISTED
Noble Energy, Inc.
NBL
$1.74M ﹤0.01%
59,600
-18,300
-23% -$501K
Z icon
3670
Zillow
Z
$8.08B
$1.74M ﹤0.01%
42,392
-150,018
-78% -$6.17M
RDS.B
3671
CALL
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$1.74M ﹤0.01%
25,400
-22,900
-47% -$1.48M
NKTR icon
3672
Nektar Therapeutics
NKTR
$2.57B
$1.73M ﹤0.01%
1,935
-5,995
-76% -$3.55M
CCS icon
3673
Century Communities
CCS
$2.04B
$1.73M ﹤0.01%
55,728
-13,098
-19% -$374K
APTI
3674
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$1.73M ﹤0.01%
73,664
+32,447
+79% +$690K
IVZ icon
3675
PUT
Invesco
IVZ
$14.3B
$1.73M ﹤0.01%
47,400
-2,700
-5% -$97.7K

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.